Data collection and surveillance are critical components of the approval process. Accurate and comprehensive data help in making informed decisions about the safety and efficacy of interventions. Post-marketing surveillance, also known as pharmacovigilance, is crucial for detecting rare or long-term adverse effects that may not have been apparent during clinical trials.
